GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.310
-0.010 (-0.76%)
Jun 23, 2026, 1:12 PM EDT - Market open
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $4.55 million as of June 23, 2026. Its market cap has decreased by -73.26% in one year.
Market Cap
4.55M
Enterprise Value
3.71M
1-Year Change
-73.26%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $4.55M, an increase of 1,796.77%. That is a compound annual growth rate of 54.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 4.55M | -38.05% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mustang Bio | 5.11M |
| Liminatus Pharma | 5.09M |
| Dermata Therapeutics | 4.95M |
| Enveric Biosciences | 4.90M |
| CollPlant Biotechnologies | 4.87M |
| TransCode Therapeutics | 4.75M |
| Alzamend Neuro | 4.64M |
| 60 Degrees Pharmaceuticals | 4.49M |